Accordingly, blockage of IKKβ-dependent NF-κB activation in intestinal epithelial cells impairs proliferation, survival, and epithelial-mesenchymal transition (EMT) of neoplastic cells, leading to important anti-tumor effects in both models of CAC and carcinogen-induced CRC [64,65]. This evidence concerns the gene NFKB1 and neoplasm.